Ophthalmology Times
CONTINUE TO SITE >

OR WAIT 15 SECS

Alcon, Advanced Medical Optics enter into IOL patent agreement

July 1, 2008

Huenenberg, Switzerland-Alcon Inc. and Advanced Medical Optics (AMO) have entered into a patent cross-licensing agreement relating to a specified one-piece IOL design and lubricious coatings for IOL insertion devices.

Huenenberg, Switzerland-Alcon Inc. and Advanced Medical Optics (AMO) have entered into a patent cross-licensing agreement relating to a specified one-piece IOL design and lubricious coatings for IOL insertion devices.

The agreement provides AMO with paid-up, non-exclusive, worldwide licenses restricted to single-piece IOLs having the same design as AMO’s recently launched IOL (Tecnis), according to a prepared statement issued by Alcon. The licenses assure AMO of freedom to operate with respect to the subject Alcon patents, relative to the launched IOL and any future IOL models having the same design platform. AMO will pay Alcon a lump sum of $10 million for those licenses, according to Alcon.

Additionally, Alcon will receive paid-up, non-exclusive, worldwide licenses under two families of patents owned by AMO, according to the statement. The licenses assure Alcon of freedom to operate with respect to the two patents, relative to the coating systems currently used in its IOL insertion devices (Monarch and AcrySert), as well as any future coating systems of a similar type that Alcon may develop. In the statement, Alcon said it will pay AMO a lump sum of $31 million for those licenses.

Other terms of the agreement were not disclosed.